Ignite Creation Date:
2025-12-25 @ 4:10 AM
Ignite Modification Date:
2025-12-26 @ 3:07 AM
Study NCT ID:
NCT04451720
Status:
COMPLETED
Last Update Posted:
2022-12-05
First Post:
2020-06-29
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study of Subcutaneous Risankizumab Injection to Assess Change in Palmoplantar Pustulosis Area and Severity Index [PPPASI] in Adult Japanese Participants With Palmoplantar Pustulosis
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-20
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-21
Completion Date Type:
ACTUAL
First Submit Date:
2020-06-29
First Submit QC Date:
None
Study First Post Date:
2020-06-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-02
Last Update Post Date:
2022-12-05
Last Update Post Date Type:
ACTUAL